Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials.

Lin A, Giuliano CJ, Sayles NM, Sheltzer JM.

Elife. 2017 Mar 24;6. pii: e24179. doi: 10.7554/eLife.24179.

2.

Single-chromosome Gains Commonly Function as Tumor Suppressors.

Sheltzer JM, Ko JH, Replogle JM, Habibe Burgos NC, Chung ES, Meehl CM, Sayles NM, Passerini V, Storchova Z, Amon A.

Cancer Cell. 2017 Feb 13;31(2):240-255. doi: 10.1016/j.ccell.2016.12.004. Epub 2017 Jan 12.

Supplemental Content

Loading ...
Support Center